{"changes":[{"companyHref":"/c/bonumtherapeutics-com","date":"2026-09-25","documentUrl":null,"domain":"bonumtherapeutics.com","fact":"latest round","name":"Bonum Therapeutics, Inc.","new":{"amountUsd":27000000,"date":"2026-04-03","lead":null,"type":null},"old":{"amountUsd":27000000,"date":"2026-04-03","lead":null,"type":"seed"},"publisher":"sec-edgar","reason":null,"retrievedAt":"2026-05-07","slug":"bonumtherapeutics-com","status":"attributed","url":"https://whoraisedwhat.com/c/bonumtherapeutics-com"}],"country":"US","description":"Antibody-controlled therapeutics with dual-binding antibodies that stay inactive until they encounter their target, focused on regulated cytokines. Targets oncology with extensions into autoimmune, metabolic, and pain indications. Differentiated by activity-on-binding antibody chemistry rather than payload chemistry.","domain":"bonumtherapeutics.com","employees":null,"founded":2021,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"biotechnology","investors":[],"lat":47.603832,"lng":-122.330062,"location":"SEATTLE, WA","name":"Bonum Therapeutics, Inc.","rounds":[{"amountQuarantined":false,"amountUsd":27000000,"currency":"USD","date":"2026-04-03","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"sec-edgar","retrievedAt":"2026-05-07","status":"attributed","url":null},"status":"attributed","type":null,"url":null}],"slug":"bonumtherapeutics-com","sources":[{"fact":"round","publisher":"sec-edgar","retrievedAt":"2026-05-07","status":"attributed","url":null},{"fact":"existence","publisher":"bonumtherapeutics.com","retrievedAt":"2026-05-07","status":"self-reported","url":"https://bonumtherapeutics.com"},{"fact":"description","publisher":"bonumtherapeutics.com","retrievedAt":"2026-05-07","status":"self-reported","url":"https://bonumtherapeutics.com"}],"stage":null,"techStack":[],"totalRaisedUsd":27000000,"updatedAt":"2026-05-07"}